| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3850113 | American Journal of Kidney Diseases | 2010 | 11 Pages |
Abstract
Microalbuminuria screening is cost-effective for patients with diabetes or hypertension, but is not cost-effective for patients with neither diabetes nor hypertension unless screening is conducted at longer intervals or as part of existing physician visits.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Thomas J. PhD, John S. BS, Joel E. BA, Nilka R. MPH, MT, Kumiko PhD, Paul PhD, Meda E. MD, PhD, Regina MPH, Susan M. DrPH, MS, Anton C. MD, MSHA, Desmond E. MD, PhD,